Clearing Amyloid-Beta by Astrocytes: The Role of Rho GTPases Signaling Pathways as Potential Therapeutic Targets
2024
Astrocytes and Rho GTPases in Alzheimer's Disease
publication
Evidence: moderate
Author Information
Author(s): Park Gyeongah, Jin Zhen, Lu Hui, Du Jianyang
Primary Institution: University of Tennessee Health Science Center
Hypothesis
Targeting Rho GTPase signaling pathways in astrocytes could enhance amyloid-beta clearance and mitigate neuroinflammation in Alzheimer's disease.
Conclusion
Astrocytes play a crucial role in clearing amyloid-beta, and targeting Rho GTPases may provide new therapeutic strategies for Alzheimer's disease.
Supporting Evidence
- Astrocytes are crucial for maintaining neuronal health and play a key role in clearing toxic amyloid-beta peptides.
- Rho GTPases regulate astrocyte function and may influence amyloid-beta clearance.
- Targeting Rho GTPase pathways could enhance astrocytic function and improve cognitive outcomes in Alzheimer's patients.
Takeaway
Astrocytes help clean up a harmful protein in the brain that causes Alzheimer's disease, and scientists think they can make this process better by focusing on certain proteins called Rho GTPases.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website